Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child

Marjan De Rademaeker*, Willem Verpoest, Martine De Rycke, Sara Seneca, Karen Sermon, Sonja Desmyttere, Maryse Bonduelle, Josianne Van der Elst, Paul Devroey, Inge Liebaers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Preimplantation genetic diagnosis (PGD) is an alternative to prenatal diagnosis for patients at risk of transmitting an inherited disease such as myotonic dystrophy type 1(DM1) to their offspring. In this paper, the clinical application of preimplantation diagnosis for DM1 upon request to children born is described in a large cohort of risk couples. PGD could be offered to all 78 couples opting for PGD regardless of the triplet repeat size. The incidence of major complications was minimalised following a careful assessment in affected DM1 females anticipating possible cardiological, obstetrical and anaesthetical problems. A live-birth delivery rate per cycle with oocyte retrieval of 20% was the outcome. Forty-eight of the 49 children born are in good health and have normal psychomotor development.

Original languageEnglish
Pages (from-to)1403-1410
Number of pages8
JournalEuropean Journal of Human Genetics
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2009
Externally publishedYes

Keywords

  • Adult
  • Female
  • Fertilization in Vitro
  • Genetic Testing
  • Humans
  • Myotonic Dystrophy/diagnosis
  • Pregnancy
  • Pregnancy Outcome
  • Preimplantation Diagnosis

Fingerprint

Dive into the research topics of 'Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child'. Together they form a unique fingerprint.

Cite this